Frank Rimerman Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,152
Closed -$374K 555
2024
Q2
$374K Buy
3,152
+2,451
+350% +$291K 0.03% 405
2024
Q1
$74.7K Buy
+701
New +$74.7K 0.01% 115
2021
Q4
Sell
-556
Closed -$214K 120
2021
Q3
$214K Buy
+556
New +$214K 0.08% 103